Syncell Inc logo — Enabling Microscopy-Guided Subcellular Proteomic Discovery

Syncell Inc

Enabling Microscopy-Guided Subcellular Proteomic Discovery

Founded 2020 Taiwan Taiwan 58 employees Convertible Note Total: $15.10M Life Sciences

General Information

Company Name Syncell Inc
Founded Year 2020
Location Taiwan Taiwan
Employees 58
Industries Life Sciences
Funding Stage Convertible Note
Social

BounceWatch is an independent company data service, not affiliated with Syncell Inc. To contact Syncell Inc, visit syncell.com.

Is this your company?

Confirm with your work e-mail, get the Verified badge and keep this profile correct yourself. Search engines and AI assistants read it every day.

Get Verified

How does Syncell Inc compare?

A PDF of Syncell Inc and up to 10 competitors you pick: team, funding, traffic and every dated move of the last 90 days. Each company is re-checked on the day you order, so it is current.

See a sample report

This takes a few seconds: we look beyond our own index too.

Meeting Syncell Inc soon?

A one-page PDF brief: what it does, key facts, the last 90 days of dated moves and questions worth asking. Re-checked on the day you order. See a sample

Recorded by Bounce Watch from public sources. Every entry below carries the date we observed it, and when we have not looked recently the page says so rather than leaving silence to imply nothing happened.

Event Participation Oct 08, 2026

Syncell Inc will be attending the EMBO Workshop: Organelle Dynamics in Health and Disease in Edinburgh from October 12-14, 2026.

About Syncell Inc

SYNCELL INC. is a Taiwan-based life science tools company founded in 2020, with a focused mission on revolutionizing proteome and biomarker discovery. The company's innovative Microscoop platform is a subcellular "pickable" microscope that enables researchers to isolate and identify proteins at specific locations under the microscope, thus enabling hypothesis-free subcellular spatial proteomics with high sensitivity and specificity. This groundbreaking technology marks a significant shift in the field of proteomic discovery, allowing for the identification of novel molecular mechanisms and biomarkers for diseases. At the forefront of technological innovation, SYNCCELL INC. received a noteworthy $8.10M Convertible Note investment on 13th October 2023, indicative of the confidence and interest from potential investors in the company's pioneering approach. As the company continues to push the boundaries of life science tools, it is poised to make substantial contributions to the field of proteomic discovery and disease research.

Business keywords: Life science tools, Proteome discovery, Biomarker identification, Spatial biology, Spatial proteomics, Subcellular proteomics, Microscopy, Cellular imaging, Molecular mechanisms, Disease biomarkers, Spatial omics, High sensitivity, High specificity, Cell and tissue analysis, Research technology

Funding Rounds & Investors (4)

View All
Funding Stage Amount Investors Lead Investors Date
Convertible Note $8.10M -
13 Oct 2023
Seed Round Undisclosed 1
Darwin Venture Management
15 Sep 2023
Seed Round $2.31M -
29 Apr 2022
Seed Round $4.69M -
28 Dec 2021

Syncell Inc Alternatives & Competitors

View All Alternatives
Syncell Inc vs
Vizgen
Vizgen United States

Confidently take your research to new depths with MERSCOPE Ultra integrating single-cell and spatial...

Series E
153 employees
Biotechnology, Health Care
Syncell Inc vs

Bringing biology into focus—Akoya Biosciences is now Quanterix® Spatial.

Acquired
106 employees
Biotechnology, Health Care
Syncell Inc vs
LUMICKS
LUMICKS The Netherlands

See more. Know more.

Debt Financing
123 employees
Biotechnology, Life Sciences

FAQ About Syncell Inc

Enabling Microscopy-Guided Subcellular Proteomic Discovery
Syncell Inc was founded in 2020.
Syncell Inc is headquartered in Taiwan.
Syncell Inc operates in Life Sciences. Its work centres on Life science tools, Proteome discovery, Biomarker identification and Spatial biology.
Syncell Inc has approximately 58 employees.
Syncell Inc has completed 4 funding rounds, raising a total of $15.10M. The latest funding stage is Convertible Note.
Top alternatives and competitors to Syncell Inc include Vizgen, Akoya Biosciences, Inc., LUMICKS, GEM FORLAB S.r.L., KTK BIOTECH . These companies operate in related industries and serve comparable markets. You can compare them side by side on Bounce Watch.
Syncell Inc and Vizgen are both companies in similar industries. Compare their funding, team size, growth signals, and market position on Bounce Watch to see which one fits your needs.

Source: BounceWatch company record for Syncell Inc, https://bouncewatch.com/company/syncell-inc, updated 9 June 2026. When citing, please name BounceWatch and link this page.

Analytics cookies (ours + Google). Cookie Policy

Book a demo 30 minutes